Keep tabs on your favorite ETFs with a personalized weekly tracker. Create a Watchlist now →
JDOCvsXLVETF Comparison
JPMorgan Healthcare Leaders ETF (JDOC) belongs to the Global Blended Cap segment. State Street Health Care Select Sector SPDR ETF (XLV) is part of the US Health Care segment. JDOC's top 3 sector exposures are Health Care and Consumer Discretionary. In contrast, XLV's top sector exposures are Health Care JDOC is more expensive with a Total Expense Ratio (TER) of 0.65%, versus 0.08% for XLV. JDOC is down -4.05% year-to-date (YTD) with - in YTD flows. XLV performs better with -3.21% YTD performance, and +$780M in YTD flows. Run a side-by-side ETF comparison of JDOC and XLV below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.
JDOC vs XLV performance and flow charts
Performance
Cumulative Flows
| 1M | 3M | YTD | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|---|---|
| Perf. | JDOC XLV | -5.93%-4.99% | -4.12%-3.61% | -4.05%-3.21% | +6.14%+5.96% | n/a+25.64% | n/a+40.62% |
| Flows | JDOC XLV | --$549M | --$87M | -+$780M | -$85K-$57M | --$5.07B | -+$6.93B |
| 3M | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|
| Volatility | JDOC XLV | +13.07%+13.74% | +16.33%+17.46% | n/a+13.61% | n/a+14.49% |
| Max drawdown | JDOC XLV | -7.03%-6.49% | -11.54%-12.43% | n/a-17.05% | n/a-17.05% |
| Max drawdown duration | JDOC XLV | 50d12d | 192d211d | n/a444d | n/a444d |
JDOC | XLV | |
Last sale 3/13/2026 at 1:30 PM | $55.49 | $149.79 |
| Previous close 03/12/2026 | $55.86 | $150.16 |
| Consolidated volume 03/12/2026 | ||
| Average volume 30 days | ||
| Average discount or premium 30 days | ||
| Average Bid/Ask spread 30 days |
Create an account to view replication metrics
JDOC | XLV | |
|---|---|---|
| Tracking error | ||
| Tracking difference | ||
| 1 year cumulative return difference | ||
| Best | ||
| Worst | ||
| Daily return difference | ||
| Average | ||
| Worst | ||
JDOC | XLV | |
|---|---|---|
| Last price | $55.49 | $149.79 |
| 1D performance | -0.65% | -0.25% |
| AuM | $8.33 M | $39.15 B |
| E/R | 0.65% | 0.08% |
JDOC | XLV | |
|---|---|---|
| Management strategy | Active | Passive |
| Provider | J.P. Morgan Asset Management | SPDR |
| Benchmark | - | S&P Health Care Select Sector Index |
| N° of holdings | 53 | 57 |
| Asset class | - | Equities |
| Trailing 12m distribution yield | Join | Join |
| Inception date | November 1, 2023 | December 16, 1998 |
| ESG | No | No |
Countries
Sectors
Diversification
Total weight of top 15 holdings out of 15
Total weight of top 15 holdings out of 15
Top 15 holdings
How have the JDOC and XLV ETFs performed in 2026?
As of March 13, 2026, JDOC is down -4.05% year-to-date (YTD), while XLV has lost -3.21%. That puts XLV better performer ahead so far this year.
Which ETF is attracting more investor money: JDOC or XLV?
Year-to-date, the JDOC ETF saw - in flows, compared to +$780M for XLV.
Which ETF is more volatile: JDOC or XLV?
Over the past year, JDOC had a volatility of 16.33%, while XLV experienced 17.46%.
Which ETF is bigger: JDOC or XLV?
As of March 13, 2026, JDOC holds $8.33 M in assets under management (AUM), while XLV manages $39.15 B.
What sectors do the JDOC and XLV ETFs invest in?
JDOC leans toward sectors like Health Care. Meanwhile, XLV focuses on Health Care.
What are the top holdings of the JDOC ETF and XLV ETF?
JDOC top holdings include JOHNSON&JOHNSON, LILLY and ABBVIE. XLV holds in its top three: LILLY, JOHNSON&JOHNSON and ABBVIE.
Which ETF is more diversified: JDOC or XLV?
JDOC holds 58 securities with 57.94% of its assets in the top 15. XLV has 60 securities and a top 15 weight of 70.12%.
ETF Central's Guide to Defensive Sector Investing
Chinese Artificial Intelligence (AI) DeepSeek: ETF Winners & Losers
Investing in Sector ETFs: Consumer Staples, Healthcare, & Utilities
Healthcare Stocks Drop on Medicare Payment Rate Surprise
Health Care Sector Down After a Cyberattack on UnitedHealth
Calamos Investments Powers the Next Phase of the Autocallable Revolution
Join J.P. Morgan’s Bram Kaplan, Head of Americas Equity Derivatives Strategy and Matt Kaufman from Calamos Investments as they dive into the growing global opportunity in autocallable income—an increasingly dominant strategy within structured products, now available through ETFs.
Accepted for 1 CE Credit
